Comparative genomic profiling of Sezary syndrome and primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma
Do two rare skin lymphomas hide different mutation clues for treatment?
This observational cohort study analyzed genomic data from 26 patients with Sezary syndrome and 13 with primary cutaneous CD8+ aggressive ep…
Two rare skin lymphomas share nearly identical mutation counts but differ in ERBB2 gene changes, offering new clues for personalized treatme…
CXCL13 quantification in PBMCs and plasma distinguishes Sézary syndrome from other cutaneous T-cell lymphomas and dermatoses.
A simple blood test could spot a rare skin cancer faster
This cohort study analyzed CXCL13 expression in peripheral blood mononuclear cells (PBMCs) and plasma concentrations in patients with suspec…
A simple blood test for a protein called CXCL13 may help doctors catch a rare, aggressive skin cancer that often looks like eczema for years…